This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Mark,_B.L.
There is no page with the exact title "Mark,_B.L.". The search results for "Mark,_B.L." are displayed below. You can create a page titled Mark,_B.L. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- User:Mark Macbeth/Sandbox14 (18,191 bytes)
1: ....org/structure/7UTZ 7UTZ]' scene='95/952709/Initial_scene_with_edited_7utz/7'>
4: ...humb|Figure 1. TSHR with TSH bound. The extracellular and transmembrane domains of the GPCR are shown...
5: ...is of thyroid hormone action. Physiol Rev. 2001 Jul;81(3):1097-142. doi: 10.1152/physrev.2001.81.3.10...
8: ...active form of the thyrotropin receptor shown in blue (PDB:[https://www.rcsb.org/structure/7T9M 7T9M]...
9: ...Tsh_7t9i/1'>α-subunit of TSH</scene> cause this clash. - User:Mark Behrens (249 bytes)
1: * Full Real Name: Mark Behrens
5: ...n (NO ABBREVIATIONS): University of Nebraska-Lincoln
7: * City, State/Province, Country: Lincoln, NE USA
9: * Field of Expertise or Study: Plant Molecular Biology/Genetics - User:Mark Brooks (128 bytes)
1: ...orking for Herman van Tilbeurgh at Yeast Structural Genomics at Orsay, near Paris, France. - Category:Mark (35 bytes)
1: List of pages with the keyword Mark - Category:Mark TL (38 bytes)
1: List of pages with the keyword Mark TL - Image:Mark Hoelzer.jpg (191 bytes)
2: ...r for BioMolecular Modeling at the Milwaukee School of Engineering.
3: == Licensing ==
4: {{subst:Non-commercial from license selector}} - User:Mark Hoelzer (554 bytes)
1: *[[User:Mark Hoelzer/Sandbox1]]
2: *[[User:Mark Hoelzer/Sandbox2]]
4: [[Image:Mark_Hoelzer.jpg]]
6: ... ( [http://www.3dmoleculardesigns.com www.3dmoleculardesigns.com]). - User:Mark Omobono (98 bytes)
1: ..., Chemical Engineering major w/ conc in Biochemical Engineering - User:Mark Bergseid (95 bytes)
1: ...s company. Superb chromatographer Proteins, enzymology, peptides - User:Mark Barnes (152 bytes)
1: ..., studying biochemistry and molecular biology. I plan to have a career in science. - Category:Sherman, Mark A (46 bytes)
1: List of pages with the keyword Sherman, Mark A - Category:Mark L (37 bytes)
1: List of pages with the keyword Mark L - User:Mark Teutsch (63 bytes)
1: Science Faculty, Deerfield Academy
2: Ph.D. University of Illinois - User:Mark Macbeth/Sandbox6 (1,166 bytes)
1: =The catalytic domain of the human RNA editing protein, ADAR...
3: <StructureSection load='1ZY7' size='900' side='right' caption='Captio...
6: ...edit this page''' to modify. Be careful with the < and > signs.
7: ...h.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
15: == Relevance == - Category:Mark Glover JN (45 bytes)
1: List of pages with the keyword Mark Glover JN - Category:Mark MA (38 bytes)
1: List of pages with the keyword Mark MA - User:Mark Leiserson (183 bytes)
1: ..., and plan on pursuing a Ph.D in Computational Biology once I graduate. - User:Mark Seif (137 bytes)
1: Graduated from Pharmacy School, University of Ainshams, Egypt.
2: Working as a Cell culture research officer in Rhein-Minapharm Biogeneti... - User:Mark Macbeth/Sandbox7 (13,983 bytes)
1: ==LSD-1: Human lysine-specific demethylase 1==
2: ...d FAD cofactor (green).' scene='81/811090/Overall_lsd-1/1'>
5: ...pped around histone proteins with histone tails (blue)]]
6: ...hylases and has been studied since its instrumental discovery in 2004 <ref name="Shi"/>.
11: ...|thumb|Figure 2: CoRest complex (purple) bound to LSD1 (PDB: 2h94) at the Tower domain.]] - User:Mark Safro (205 bytes)
1: ... of Crystallography and Institute of Molecular Biology, 1980.
Page text matches
- 2cfi (4,487 bytes)
2: ... domain of human 10-FTHFD in complex with 6- formyltetrahydropterin==
3: ...' side='right'caption='[[2cfi]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2CFI FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85Å</td></tr> - 2bw0 (4,342 bytes)
2: ...he hydrolase domain of Human 10-Formyltetrahydrofolate 2 dehydrogenase==
3: ...' side='right'caption='[[2bw0]], [[Resolution|resolution]] 1.70Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2BW0 FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7Å</td></tr> - 1kde (4,832 bytes)
2: ... OCEAN POUT ANTIFREEZE PROTEIN TYPE III ISOFORM HPLC12 MUTANT, NMR, 22 STRUCTURES==
3: <StructureSection load='1kde' size='340' side='right'caption='[[1kde]...
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1KDE FirstGlance]. <br>
6: ...]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1kdf (5,204 bytes)
2: ... OCEAN POUT ANTIFREEZE PROTEIN TYPE III ISOFORM HPLC12 MUTANT, NMR, MINIMIZED AVERAGE STRUCTURE==
3: <StructureSection load='1kdf' size='340' side='right'caption='[[1kdf]...
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1KDF FirstGlance]. <br>
6: ...]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2j0q (5,659 bytes)
2: ...ructure of the Exon Junction Complex at 3.2 A resolution==
3: ...' side='right'caption='[[2j0q]], [[Resolution|resolution]] 3.20Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2J0Q FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.2Å</td></tr> - 2j0s (5,565 bytes)
2: ...ructure of the Exon Junction Complex at 2.2 A resolution==
3: ...' side='right'caption='[[2j0s]], [[Resolution|resolution]] 2.21Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2J0S FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.21Å</td></tr> - 1czi (4,827 bytes)
2: ==CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972==
3: ...' side='right'caption='[[1czi]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1CZI FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> - 2uxn (6,874 bytes)
2: ...tural Basis of Histone Demethylation by LSD1 Revealed by Suicide Inactivation==
3: ...' side='right'caption='[[2uxn]], [[Resolution|resolution]] 2.72Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2UXN FirstGlance]. <br>
6: ...A</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> - 8txv (3,868 bytes)
2: ...lated at histone H2A K15 in complex with RNF168 (Class 1)==
3: ...' side='right'caption='[[8txv]], [[Resolution|resolution]] 3.80Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=8TXV FirstGlance]. <br>
6: ..."methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.8Å</td></tr> - 2p8l (4,514 bytes)
2: ...tibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN==
3: ...' side='right'caption='[[2p8l]], [[Resolution|resolution]] 2.44Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2P8L FirstGlance]. <br>
6: ...]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2p8m|2p8m]], [[2p8p|... - 2p8m (4,534 bytes)
2: ...plex with gp41 Peptide ELLELDKWASLWN in new crystal form==
3: ...' side='right'caption='[[2p8m]], [[Resolution|resolution]] 2.70Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2P8M FirstGlance]. <br>
6: ...tyle='overflow: auto; max-height: 3em;'>[[2p8l|2p8l]], [[2p8p|2p8p]]</div></td></tr> - 2p8p (4,690 bytes)
2: ...Antibody 2F5 in complex with gp41 Peptide LELDKWASLW[N-Ac]==
3: ...' side='right'caption='[[2p8p]], [[Resolution|resolution]] 2.70Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2P8P FirstGlance]. <br>
6: ...:]]</b></td><td class="sblockDat"><scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> - 2pr4 (4,560 bytes)
2: ==Crystal Structure of Fab' from the HIV-1 Neutralizing Antibody 2F5==
3: ...' side='right'caption='[[2pr4]], [[Resolution|resolution]] 2.05Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=2PR4 FirstGlance]. <br>
6: ...tyle='overflow: auto; max-height: 3em;'>[[2p8l|2p8l]], [[2p8m|2p8m]], [[2p8p|2p8p]]</div></td></tr> - 1djs (11,740 bytes)
2: ...ION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1==
3: ...' side='right'caption='[[1djs]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1DJS FirstGlance]. <br>
6: ...IONINE'>MSE</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> - 1f62 (4,294 bytes)
3: <StructureSection load='1f62' size='340' side='right'caption='[[1f62]...
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1F62 FirstGlance]. <br>
6: ...]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
7: ... class="sblockDat" id="ligandDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> - 1jak (5,186 bytes)
2: ...mido-3,4-dihydroxy-5-hydroxymethyl-piperidinium chloride (IFG)==
3: ...' side='right'caption='[[1jak]], [[Resolution|resolution]] 1.75Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1JAK FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.75Å</td></tr> - 1nou (3,760 bytes)
2: ==Native human lysosomal beta-hexosaminidase isoform B==
3: ...' side='right'caption='[[1nou]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1NOU FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4Å</td></tr> - 1now (3,976 bytes)
2: ...ihydroxy-5-Hydroxymethyl-Piperidinium Chloride (GalNAc-isofagomine)==
3: ...' side='right'caption='[[1now]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1NOW FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> - 1np0 (5,693 bytes)
2: ...B in complex with intermediate analogue NAG-thiazoline==
3: ...' side='right'caption='[[1np0]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1NP0 FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> - 1p27 (3,325 bytes)
2: ==Crystal Structure of the Human Y14/Magoh complex==
3: ...' side='right'caption='[[1p27]], [[Resolution|resolution]] 2.00Å' scene=''>
4: == Structural highlights ==
5: ...ttps://proteopedia.org/fgij/fg.htm?mol=1P27 FirstGlance]. <br>
6: ...d="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
